implementation

Digital

In a market saturated with articles highlighting the potential of generative AI, it’s crucial to also understand its limitations.

Digital

For AI to be transformative in the pharmaceutical industry, it must be designed with a security-first approach.

Oncology

At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.